ArticleAmerican journal of cancer research2021

CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma.

Chiara Galimberti et al.PubMed ↗Full text ↗

No numbers read from the abstract.